Log In
Print this Print this

MC01 (formerly PN107)

  Manage Alerts
Collapse Summary General Information
Company Axcella Health Inc.
DescriptionOrally ingested protein with an amino acid combination and physicochemical profile optimized for myopenia conditions
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationMuscular atrophy
Indication DetailsTreat muscular atrophy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today